Xiwen Bi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Breast Cancer Risk

Ejection Fraction

Atomic Force Microscopy

Top Venues

Cancer medicine

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Mei-Ting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shu-Sen Wang, Yanxia Shi, Xin An
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer medicine (2023)
Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Mei-Ting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shu-Sen Wang, Yanxia Shi, Xin An
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer medicine (2023)
Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Mei-Ting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shu-Sen Wang, Yanxia Shi, Xin An
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer medicine (2023)
Yuyu Ma, Fangfang Duan, Yue Zhuang, Chenge Song, Jiajia Huang, Wen Xia, Ruoxi Hong, Qiufan Zheng, Shusen Wang, Yanxia Shi, Fei Xu, Zhongyu Yuan, Xiwen Bi
Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study. Journal of oncology 2022 (2022)